A multicentre randomised trial comparing the efficacy and safety of Remogen® Omega versus Cationorm® in the treatment of patients suffering from dry eye
Purpose Remogen® Omega is the first omega‐3 containing drop indicated in the treatment of dry eye syndrome (DES). It contributes to the maintenance of the physicochemical balance of the tear film and facilitates eye recovery. The aim of this study was to compare the efficacy and safety of Remogen® O...
Gespeichert in:
Veröffentlicht in: | Acta ophthalmologica (Oxford, England) England), 2022-01, Vol.100 (S267), p.n/a |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!